Senate bill S.4031 would establish VA Centers of Excellence to study psychedelic therapies — including MDMA, psilocybin, ibogaine, and ketamine — for veterans with PTSD, TBI, depression, and chronic pain. The bipartisan legislation, introduced by Sens. Gallego and McCormick, marks one of the most serious federal moves yet to bring psychedelic research inside a functioning healthcare institution.
The post Senate Bill S.4031 Signals a Federal Turn Toward Psychedelic Medicine appeared first on Psychedelics Today.
